» Authors » Veronique Brouste

Veronique Brouste

Explore the profile of Veronique Brouste including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 1444
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Palmieri L, Belaroussi Y, Huchet N, Fonck M, Bellara C, Brouste V, et al.
Dig Liver Dis . 2024 May; 56(11):1930-1937. PMID: 38763795
Background: The impact of local management of pulmonary metastases on the disease course of patients with metastatic colorectal cancer is poorly assessed. Methods: REPULCO database was a retrospective cohort on...
2.
Khalifa E, Chapusot C, Tournier B, Sentis J, Marion E, Remond A, et al.
J Clin Pathol . 2022 Jul; 76(10):698-704. PMID: 35820776
Aims: Idylla epidermal growth factor receptor () is a fast and fully automated mutation assay that is easy to implement. However, under the Biocartis-recommended technical conditions, tissue sections are directly...
3.
Jones N, Gros A, Velasco V, Dapremont V, Brouste V, Gastaldello B, et al.
Cancer Genet . 2022 Mar; 264-265:8-15. PMID: 35263698
The similarities between sporadic basal-like breast cancer (BLBC) and BRCA1-mutated breast tumours raise the possibility that deregulation of the same pathway may underlie these tumour types. The aim of this...
4.
Deleau F, Linck P, Brouste V, Thomassin-Naggara I, Depetiteville M, Boisserie-Lacroix M, et al.
AJR Am J Roentgenol . 2022 Feb; 219(1):37-45. PMID: 35170358
A recently introduced digital breast tomosynthesis (DBT) device allows acquisition of DBT spot compression views with a small paddle during DBT acquisition. The purpose of this study was to evaluate...
5.
Bertolaso P, Brouste V, Cazeau A, de Clermont-Gallerande H, Bladou F, Cabart M, et al.
Clin Genitourin Cancer . 2022 Feb; 20(3):297-297.e6. PMID: 35101381
Introduction: Guidelines do not recommend FDG-PET CT for the staging of MIBC as a standard. The objectives of the study are to assess the accuracy of the FDG-PET CT for...
6.
Morgat C, Brouste V, Chastel A, Velasco V, MacGrogan G, Hindie E
Breast Cancer Res Treat . 2021 Oct; 190(3):403-413. PMID: 34596798
Purpose: Neurotensin receptor-1 (NTS) is increasingly recognized as a potential target in diverse tumors including breast cancer, but factors associated with NTS expression have not been fully clarified. Methods: We...
7.
Mangiardi-Veltin M, Chammings F, Jaffre A, Rousvoal A, Tunon de Lara C, Brouste V, et al.
Bull Cancer . 2021 Sep; 108(11):999-1009. PMID: 34556291
Introduction: Women identified as high-risk for breast cancer may choose between close follow-up and radical mastectomy. Prophylactic mastectomy, as any other surgery, is associated with benefits and harms. The aim...
8.
Alran L, Chammings F, Auriol-Leizagoyen S, Velasco V, Deleau F, Brouste V, et al.
Histopathology . 2021 Aug; 80(2):304-313. PMID: 34403159
Aims: Breast hamartomas are an under-recognised lesion because they lack a distinctive microscopic appearance. Microscopic diagnosis can often conclude 'no significant lesion' or 'normal breast tissue', leading to repeated biopsies...
9.
Boisserie-Lacroix M, Doutriaux-Dumoulin I, Chopier J, Boyer B, Depetiteville M, Hoppe S, et al.
Eur Radiol . 2021 Apr; 31(10):7783-7791. PMID: 33846843
Objectives: To evaluate the diagnostic accuracy of breast MRI in identifying lesions requiring excision for patients with suspicious nipple discharge but normal mammograms and ultrasounds. Methods: Between September 2013 and...
10.
Gonnet A, Salabert L, Roubaud G, Catena V, Brouste V, Buy X, et al.
BMC Cancer . 2019 Dec; 19(1):1182. PMID: 31795959
Background: To determine safety and efficacy of radiofrequency ablation (RFA) for local treatment of lung metastases of renal cell carcinoma (RCC), sequenced or combined with systemic treatments. Methods: Retrospectively, we...